Skip to main content

Table 1 The demographic data of the subjects in this study

From: A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty

 

PAI TXA group (n = 49)

IAI TXA group (n = 36)

Control group (n = 42)

P value

Age (years)

68.5 ± 7.4

69.7 ± 7.2

69.6 ± 5.7

0.66

Gender (M/F)

8/41

5/31

10/32

0.48

Height (m)

1.6 ± 0.1

1.6 ± 0.1

1.6 ± 0.1

0.49

Weight (kg)

67.6 ± 11.7

65.1 ± 10.4

67.9 ± 9.3

0.44

BMI (kg/cm2)

25.9 ± 3.7

25.6 ± 3.9

26.6 ± 3.8

0.47

Preoperative Hb (g/L)

124.3 ± 10.5

123.8 ± 10.7

125.9 ± 12.9

0.69

INR

0.98 ± 0.2

0.95 ± 0.1

0.94 ± 0.0

0.38

PT (s)

11.5 ± 2.5

11.1 ± 0.7

11.1 ± 0.6

0.33

APTT (s)

27.0 ± 4.3

27.0 ± 3.3

27.0 ± 2.9

0.99

PLT (×109/L)

213.7 ± 77.8

212.1 ± 63.5

212.8 ± 61.1

0.99

Operation time (min)

94.5 ± 16.4

92.1 ± 13.3

88.5 ± 10.3

0.12

Anticoagulant use, % yes

8.2

11.1

9.5

0.90

Thromboembolic tendency, % yes

14.3

11.1

14.3

0.89

Coagulopathies, % yes

2

0

0

0.20

  1. Values are expressed as the mean ± standard deviation
  2. PAI TXA peri-articular injection of tranexamic acid, IAI TXA intra-articular injection of tranexamic acid, BMI body mass index, Hb hemoglobin, INR international normalized ratio, PT prothrombin, APTT activated partial thromboplastin time, PLT platelet